Black Maple Capital Management’s bluebird bio BLUE Stock Holding History

Black Maple Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-60,197	Closed	-$294K	–	99
2025 Q1	$294K	Buy	+60,197	New	+$362K	0.16%	65

Other funds holding BLUE

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Black Maple Capital Management's BLUE Position: Q2 2025 in Review

Black Maple Capital Management sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 60,197 shares — an estimated $294K sold.

Black Maple Capital Management first reported a position in BLUE in Q1 2025 and held it in 1 quarter. The position peaked at $294K in Q1 2025. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

Black Maple Capital Management reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
Black Maple Capital Management sold 60,197 bluebird bio shares in Q2 2025, an estimated $294K.
Black Maple Capital Management first reported a position in bluebird bio in Q1 2025 and held it in 1 quarter.
Black Maple Capital Management's bluebird bio position peaked at $294K in Q1 2025.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Black Maple Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.